LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.017783
 49.63 27.76 168 4818 0.0349 0.2738
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 49.63 27.76 1410 4818 0.2927 0.6955
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 51.33 27.76 998 5117 0.1950 0.6096
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 51.33 27.76 1007 5117 0.1968 0.6115
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 51.33 27.76 173 5117 0.0338 0.2752
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 51.33 27.76 1452 5117 0.2838 0.6918
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 53.04 27.76 1088 5365 0.2028 0.6210
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 53.04 27.76 1098 5365 0.2046 0.6230
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 53.04 27.76 187 5365 0.0349 0.2855
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 53.04 27.76 1435 5365 0.2674 0.6812
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 54.74 27.76 1081 5606 0.1928 0.6132
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 54.74 27.76 1088 5606 0.1941 0.6145
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 54.74 27.76 199 5606 0.0355 0.2933
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 54.74 27.76 1572 5606 0.2804 0.6940
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 56.45 27.76 1122 5745 0.1953 0.6174
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 56.45 27.76 1130 5745 0.1967 0.6189
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 56.45 27.76 197 5745 0.0343 0.2901
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 56.45 27.76 1595 5745 0.2776 0.6931
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 58.15 27.76 1172 5906 0.1984 0.6226
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 58.15 27.76 1181 5906 0.1999 0.6242
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 58.15 27.76 199 5906 0.0337 0.2901
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 58.15 27.76 1560 5906 0.2641 0.6837
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 59.85 27.76 1147 6062 0.1892 0.6143
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 59.85 27.76 1157 6062 0.1908 0.6161
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 59.85 27.76 199 6062 0.0328 0.2885
MN20160318_Q01
N22